Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X active specific transcript (XACT) is a human, primate-specific long non-coding RNA (lncRNA) that is expressed from and coats the active X chromosome in pluripotent human embryonic stem cells[1][2][3][4][5]. Unlike most lncRNAs involved in X-chromosome silencing, such as XIST, XACT is not conserved in mice and appears unique to primate development[2][3]. XACT's expression is limited to pluripotent and early developmental states and decreases upon differentiation[2][3]. It is hypothesized to play a regulatory role in X-chromosome dosage compensation and possibly to modulate or antagonize the gene-silencing activity of XIST, preventing premature X-chromosome inactivation prior to implantation. It does not directly encode a protein or act as a therapeutic target (such as a receptor, enzyme, or transporter)[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X active specific transcript (XACT).